These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10608165)

  • 61. HRT to prevent cardiovascular disease. What studies show, how to advise patients.
    Wood MJ; Cox JL
    Postgrad Med; 2000 Sep; 108(3):59-60, 63-6, 69-72. PubMed ID: 11004936
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cardioprotective effect of hormone replacement therapy. Benefits women with established cardiovascular disease.
    Spiers D
    BMJ; 1994 Sep; 309(6957):809. PubMed ID: 7848431
    [No Abstract]   [Full Text] [Related]  

  • 63. Is physical activity as effective in reducing risk of cardiovascular disease as estrogen replacement therapy in postmenopausal women?
    Wong S; Wong J
    Int J Nurs Stud; 1999 Oct; 36(5):405-14. PubMed ID: 10519685
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cardiovascular disease risk and hormone replacement therapy (HRT): a review based on randomised, controlled studies in postmenopausal women.
    van Baal WM; Kooistra T; Stehouwer CD
    Curr Med Chem; 2000 May; 7(5):499-517. PubMed ID: 10702621
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Cardiovascular disease and hormone replacement therapy].
    Aldrighi JM; Martinez TL; da Silva Filho CP
    Arq Bras Cardiol; 1995 Sep; 65(3):249-54. PubMed ID: 8579513
    [No Abstract]   [Full Text] [Related]  

  • 66. Impact of postmenopausal hormone therapy on cardiovascular events and cancer. Study's conclusions were incorrect.
    Col NF; Wong JB; Pauker SG; Karas R
    BMJ; 1997 Sep; 315(7109):678; author reply 678-9. PubMed ID: 9310580
    [No Abstract]   [Full Text] [Related]  

  • 67. Can a healthy endothelium influence the cardiovascular effects of hormone replacement therapy?
    Koh KK
    Int J Cardiol; 2003 Jan; 87(1):1-8. PubMed ID: 12468049
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of postmenopausal hormone therapy on cardiovascular events and cancer. Paper's main conclusion is no longer justified when data from all trials are considered.
    Seagroatt V
    BMJ; 1997 Sep; 315(7109):677; author reply 678-9. PubMed ID: 9310577
    [No Abstract]   [Full Text] [Related]  

  • 69. Estrogens, homocysteine, vasodilatation and menopause: basic mechanisms, interactions and clinical implications.
    Smolders RG; van der Mooren MJ; Sipkema P; Kenemans P
    Gynecol Endocrinol; 2003 Aug; 17(4):339-54. PubMed ID: 14503980
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Issues of hormone replacement therapy and cardiovascular disease for elderly women.
    Limacher MC
    Am J Geriatr Cardiol; 2002; 11(4):217-22. PubMed ID: 12091770
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Cardiovascular risk and estrogens].
    Franeková J; Koliba P; Jabor A; Pohlídal A; Holub Z
    Ceska Gynekol; 2006 Dec; 71(6):483-9. PubMed ID: 17236409
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Postmenopausal estrogen therapy and cardiovascular disease].
    Tepper R; Goldberger S; May J; Cohen I; Beith Y
    Harefuah; 1991 Jun; 120(11):653-7. PubMed ID: 1937214
    [No Abstract]   [Full Text] [Related]  

  • 73. Hormone therapy in perimenopausal and postmenopausal women: examining the evidence on cardiovascular disease risks.
    Plonczynski DJ; Plonczynski KJ
    J Gerontol Nurs; 2007 May; 33(5):48-55. PubMed ID: 17511335
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Postmenopausal hormone replacement therapy as antiatherosclerotic therapy.
    Hodis HN; Mack WJ; Lobo R
    Curr Atheroscler Rep; 2002 Jan; 4(1):52-8. PubMed ID: 11772423
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Various actions of oestrogens on the vascular system.
    Stevenson JC
    Maturitas; 1998 Sep; 30(1):5-9. PubMed ID: 9819777
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Cardiovascular impact of postmenopausal hormone therapy: new data].
    Gaspard U
    Rev Med Liege; 1997 Apr; 52(4):224-9. PubMed ID: 9273612
    [No Abstract]   [Full Text] [Related]  

  • 77. Estrogens and the cardiovascular system: role of estradiol metabolites in hormone replacement therapy.
    Lippert TH; Seeger H; Mueck AO
    Climacteric; 1998 Dec; 1(4):296-301. PubMed ID: 11907937
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Estrogen replacement therapy: implications for postmenopausal women with end-stage renal disease.
    Mattix H; Singh AK
    Curr Opin Nephrol Hypertens; 2000 May; 9(3):207-14. PubMed ID: 10847319
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hormone replacement therapy. Should be used selectively.
    Stevenson JC; Baum M
    BMJ; 1994 Jul; 309(6948):191-2. PubMed ID: 8044103
    [No Abstract]   [Full Text] [Related]  

  • 80. Oestrogens: molecular mechanisms of cardioprotection.
    Wiseman H
    Biochem Soc Trans; 1997 Feb; 25(1):31-2. PubMed ID: 9056837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.